These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 3490614
1. Properties of 3H-MPTP binding sites in human blood platelets. Del Zompo M, Bernardi F, Bonuccelli U, Maggio R, Bajorek M, Arnone M, Corsini GU. Life Sci; 1986 Nov 17; 39(20):1885-91. PubMed ID: 3490614 [Abstract] [Full Text] [Related]
2. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies. Del Zompo M, Piccardi MP, Bernardi F, Bonuccelli U, Corsini GU. Brain Res; 1986 Jul 23; 378(2):320-4. PubMed ID: 3089539 [Abstract] [Full Text] [Related]
3. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y, Mash D, Zhang SH, Stein I. Mol Pharmacol; 1991 Mar 23; 39(3):385-93. PubMed ID: 1848660 [Abstract] [Full Text] [Related]
7. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW, Robertson DW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1987 Feb 23; 240(2):415-20. PubMed ID: 3100775 [Abstract] [Full Text] [Related]
13. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1985 Mar 23; 232(3):696-701. PubMed ID: 3871853 [Abstract] [Full Text] [Related]
15. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. Youngster SK, Sonsalla PK, Sieber BA, Heikkila RE. J Pharmacol Exp Ther; 1989 Jun 23; 249(3):820-8. PubMed ID: 2786564 [Abstract] [Full Text] [Related]
16. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase. Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M. J Pharmacol Exp Ther; 1986 Aug 23; 238(2):648-52. PubMed ID: 3488394 [Abstract] [Full Text] [Related]
18. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE. Life Sci; 1988 Aug 23; 42(3):263-71. PubMed ID: 3121972 [Abstract] [Full Text] [Related]
19. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Heikkila RE, Kindt MV, Sonsalla PK, Giovanni A, Youngster SK, McKeown KA, Singer TP. Proc Natl Acad Sci U S A; 1988 Aug 23; 85(16):6172-6. PubMed ID: 3137566 [Abstract] [Full Text] [Related]